| Code | 2739E | ||||||||||
| MA number | 16/0027/23-S | ||||||||||
| Product Form: | tbl flm 60x2,5 mg (fľ.HDPE) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 25.01.2023 |
| Validity: | 25.01.2028 |
| SPC: |
SPC_Apixaban Teva Slovakia 2,5 mg_06.2023.pdf
|
| PIL: |
PIL_Apixaban Teva Slovakia 2,5 mg_03.2024.pdf
|
| Safety feature | Yes |
| Data update: | 26.01.2023 |
